U.S. Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers
Glass House Brands Inc (GLASF) Q3 2024 Earnings Call Highlights: Record Production Growth Amid Market Challenges
Glass House Brands Inc (GLASF) reports significant production increases and operational efficiencies, while navigating pricing pressures and market volatility. Nov 14, 2024
GuruFocus News Drug Manufacturers
Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive Net Income and Strategic Growth Initiatives
Aytu BioPharma Inc (AYTU) achieves its first-ever positive net income, while expanding its ADHD and pediatric portfolios amidst revenue challenges. Nov 14, 2024
GuruFocus News Drug Manufacturers
Vireo Growth Inc (VREOF) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Expansions Amid Operational Challenges
Vireo Growth Inc (VREOF) reports a 6.2% revenue increase, driven by Maryland's market gains, while navigating capacity constraints and regulatory hurdles. Nov 14, 2024